Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.
Josephine Kam Tai K DermawanSarah ChiangSamuel SingerBhumika JadejaMartee L HensleyWilliam D TapSujana MovvaRobert G MakiCristina R AntonescuPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Compared with traditional clinicopathologic models, genomic risk stratification demonstrates superior prediction of clinical outcome in STLMS and is comparable in ULMS.